The Role of Platelets in Tumor Microenvironment
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Tumor Microenvironment".
Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 12366
Special Issue Editor
Interests: Inflammation; Platelets; Thrombosis; Fibrinolysis; Hemostasis; Mouse Models; Flow Cytometry; Platelet; Thromboinflammatory Diseases Aggregation; Platelet Activation
Special Issue Information
Dear Colleagues,
Over the last few decades, an increasing number of studies have reported on the role of platelets in the tumor microenvironment, independent of their well-established contributions to hemostasis and thrombosis. The relationship between platelets and tumor cells is bidirectional. Tumor cells can activate platelets and, conversely, platelets can influence tumor growth and metastasis. Platelets also promote tumor cells’ intravasation and extravasation.
The mechanism by which platelets contribute to the tumor microenvironment is still under debate. Some studies have reported a role for platelet-derived factors in tumor cell proliferation, while others suggest an antiproliferative effect of platelet-derived microparticles.
Preclinical and clinical research show that solid tumor growth is dependent on angiogenesis. It is now well established that platelets are involved in tumor-induced angiogenesis, and recent studies have also shown that they also participate in tumor vessel homeostasis. These observations raise the intriguing possibility that targeting platelets can destabilize the tumor vasculature and may improve the delivery of chemotherapeutic agents.
In this Special Issue, the role of platelets in tumor angiogenesis and in the maintenance of vascular integrity, as well as the role of platelets in chemotherapy resistance will be discussed.
Dr. Yacine Boulaftali
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- platelets
- solid tumor
- angiogenesis
- vascular integrity
- chemotherapy resistance